Quality of life, symptom profile and clinical efficacy of second-line treatment with dasatinib in patients with imatinib-resistant or -intolerant chronic myeloid leukemia: results... by T. I. Ionova, T. P. Nikitina, E. G. Lomaia, G. B. Kuchma, E. R. Machyulaytene, E. I. Usacheva, T. V. Shnaider, A. Yu. Rodionova, K. A. Kurbatova

Get full text